Profil bibliographique

Martín Emilio Lázaro Quintela

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

8Publications signalées

283Citations signalées

2Affiliations récentes

Institutions déclarées

University Hospital Complex Of Vigo Galicia Sur Biomedical Foundation

Domaines associés

Cancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentLung Cancer Treatments and MutationsHealth Systems, Economic Evaluations, Quality of LifeEconomic and Financial Impacts of Cancer

Publications récentes

2026 preprint

Baseline intratumoral TCRbeta; and TCRgamma; repertoires predict response to immune checkpoint inhibitors in advanced renal cell carcinoma

Manuel Pino Gonzalez, Martín Emilio Lázaro Quintela, Guillermo de Velasco Oria de Rueda, Marta Dueñas Porto et autres

0 citationsmedRxiv

Accès ouvert 2026 article

Clinical outcomes and survival in patients with NSCLC and EGFR exon 20 mutations: evidence from real-world clinical practice in a retrospective study in Galicia

B. Campos Balea, Martín Emilio Lázaro Quintela, Ma Carmen Areses Manrique, Cristina Azpitarte Raposeiras et autres

0 citationsFrontiers in Oncology

2020 conference-abstract

ECO Experts’ consensus on establishing renal cancer healthcare quality measures in Spain.

Vicente Guillém, Javier Puente, Carlos Camps, Miguel Á. Climent Durán et autres

0 citationsJournal of Clinical Oncology

2020 article

Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial

Yi‐Long Wu, Ying Cheng, Jianying Zhou, Shun Lü et autres

265 citationsThe Lancet Respiratory Medicine

2020 conference-abstract

Expert consensus on the development of quality care measures for kidney cancer in Spain.

Vicente Guillém, Carlos Camps, Miguel Á. Climent Durán, Aranzazu González del Alba et autres

0 citationsJournal of Clinical Oncology

2020 conference-abstract

Randomized phase II study of docetaxel (D) + abiraterone acetate (AA) versus D after disease progression to first-line AA in metastatic castration-resistant prostate cancer (mCRPC): ABIDO-SOGUG Trial.

Miguel Á. Climent Durán, Albert Font, Ignacio Durán, Javier Puente et autres

2 citationsJournal of Clinical Oncology

2019 conference-abstract

Analysis of the relationship between ratio N/L and survival in lung cancer patients treated with immunotherapy.

Noemí Álvarez, Marinha Costa Rivas, Sara Agraso Busto, Diego Pereiro Corbacho et autres

1 citationJournal of Clinical Oncology

2007 article

Renal primary angiosarcoma

Bruno Lopez, Isaura Fernández Pérez, Jesús Álvarez, Martín Emilio Lázaro Quintela et autres

15 citationsClinical & Translational Oncology

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.